Editas Medicine, Inc. - Common Stock — 분기별 재무 통계 (NASDAQ:EDIT)

Financials

영업활동으로 인한 현금 -50.76 M-47.8 M-50.21 M-30.84 M-36.39 M-23.06 M -140.5 M 투자 활동으로 인한 현금 30.96 M56.39 M42.65 M39.57 M58 K64 K 82.34 M 재무활동으로 인한 현금 55.51 M-1.44 M7.41 M17.17 M17.33 M0 41.91 M 잉여 현금 흐름 -50.76 M-47.8 M-50.21 M-30.84 M-36.39 M-23.06 M -140.5 M

Editas Medicine, Inc. - Common Stock

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

EDIT

Financials

Editas Medicine, Inc. - Common Stock

뉴스

Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT)

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Company News for May 6, 2026

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

에디타스 메디신, 유전자 치료 진전으로 Jones Trading 투자의견 상향

Jones Trading upgrades Editas Medicine stock rating on gene therapy progress

Baird, 이디타스 메디슨 주식 등급 ’시장수익률 상회’ 유지

Baird reiterates Editas Medicine stock rating on pipeline progress